Formulated Methylene Blue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Formulated Methylene Blue, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue [Phase 3]